Author: et

BrainAu Released China’s First Significant Scientific Research Findings on Optimal Digital Training Doses of AI Cognitive Therapeutics for Pediatric Patients, Demonstrating the Dose-Response Relationship, Further Consolidating its Leading Position in the Global DTx Markets

HONG KONG, Sept 9, 2026 – (ACN Newswire via SeaPRwire.com) – China’s No.1 cognitive digital therapeutics company – BrainAurora Medical Technology Limited (“BrainAu”)(Stock code:06681.HK) is pleased to announce that the Company’s scientific research team and the team of Professor Ni Xin

More